TG and neoplasm: When thyroglobulin levels increase in the absence of structurally identifiable disease, patients are classified as having a biochemical incomplete response to therapy and they may elect to receive an ablative or an adjuvant dose of radioactive iodine to facilitate follow-up of their tumor markers.